Klinisk Biokemi i Norden · 1 2014
| 39
5. Kellum JA, Bellomo R, Ronco C, Mehta R,
Clark W, Levin NW. The 3rd International
Consensus Conference of the Acute Dialysis
Quality Initiative (ADQI). Int J Artif Organs
2005;28:441-4.
6. Mehta RL, Kellum JA, Shah SV, et al. Acute
Kidney Injury Network: report of an initiative
to improve outcomes in acute kidney injury.
Crit Care 2007;11:R31.
7. Kellum JA, Lameire N, for the KAKIGWG.
Diagnosis, evaluation, and management of
acute kidney injury: a KDIGO summary (Part
1). Crit Care 2013;17:204.
8. Puthucheary ZA, Rawal J, McPhail M, et al.
Acute skeletal muscle wasting in critical ill-
ness. JAMA 2013;310:1591-600.
9. Grubb A. Non-invasive estimation of glo-
merular filtration rate (GFR). The Lund
model: Simultaneous use of cystatin C- and
creatinine-based GFR-prediction equations,
clinical data and an internal quality check.
Scand J Clin Lab Invest 2010;70:65-70.
10. Martensson J, Martling CR, Oldner A, Bell M.
Impact of sepsis on levels of plasma cystatin C
in AKI and non-AKI patients. Nephrol Dial
Transplant 2012;27:576-81.
11. Bell M, Granath F, Martensson J, Lofberg E,
Ekbom A, Martling CR. Cystatin C is cor-
related with mortality in patients with and
without acute kidney injury. Nephrol Dial
Transplant 2009;24: 3096-102.
12.Martensson J, Bell M, Oldner A, Xu S, Venge
P, Martling CR. Neutrophil gelatinase-asso-
ciated lipocalin in adult septic patients with
and without acute kidney injury. Intensive
Care Med 2010;36:1333-40.
13. Kashani K, Al-Khafaji A, Ardiles T, et al.
Discovery and validation of cell cycle arrest
biomarkers in human acute kidney injury.
Crit Care 2013;17:R25.
Foto: Henrik Alfthan.
